268 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (71)
- Autoimmune Disorders (1)
- Blood Disorders (3)
- Bone & Muscle (1)
- Cancer (16)
- COVID-19 (Coronavirus) (4)
- Endocrine & Metabolic Disease (2)
- Healthy Volunteers (8)
- Heart Disease (14)
- Kidney Disease (1)
- Liver Disease (1)
- Lung Disease (2)
- Neurological Disorders (3)
- Nutrition (1)
- Obstetrics & Gynecology (2)
- Pediatrics (7)
- Surgery (2)
- Transplant (3)
Displaying 1 - 1 of 1
Condition: Cancer / Leukemia
Investigator: Todd Rosenblat, MD
Status: Closed
The goal of this research study is to find the safest highest dose of SL-401 that can be given to patients with AML or BPDCN. This study will also look at how SL-401 stops or slows leukemia or BPDCN growth and how SL-401 enters and leaves the body. This study will also look at certain proteins in the …
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website,
you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the
Columbia University Website Cookie Notice.
I AGREE